Celestia Higano

Prof. Dr. Celestia Higano

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Current Oncology
Verified
Journal Article
Open access
PDF file
Sylvie D. LambertSylvie D. Lambert
Sylvie D. Lambert
LDLindsay Duncan
Lindsay Duncan
S.Nicole Culos-ReedS.Nicole Culos-Reed
S.Nicole Culos-Reed
LHLaura Hallward
Laura Hallward
CHCelestia Higano
Celestia Higano
Stuart PeacockStuart Peacock
Stuart Peacock
Background: Prostate cancer is the most common cancer diagnosis among men. Family caregivers (often female spouses) play a key role in ensuring patients’ needs are met, frequently assuming their role with no formal training, which can contribute to a high burden. The purpose of this study was to pilot TEMPO—the first dyadic, Tailored, wEb-based, psychosocial and physical activity self-Management PrOgram for men with prostate cancer and their caregivers. Methods: 49 men with prostate cancer and their caregivers were randomized to TEMPO or usual care. Baseline and follow-up questionnaires were completed to assess feasibility, acceptability, and clinical significance. A priori benchmarks for these outcomes were set. Thirteen exit interviews were conducted to further explore acceptability. Results: Feasibility benchmarks were met with the exception for recruitment with on average 6.1 dyads recruited/month (benchmark: 8 dyads/month). Benchmarks of acceptability focused on attrition (<25%) and system usability, which were met. Using the strict criteria for adherence of 100% of the module viewed and participants spending at least 15 min on the module, 45% of participants were adherent. The clinical significance on anxiety and quality of life was supported for caregivers, and mostly supported for the men with prostate cancer. Conclusion: This pilot trial was successful, with minor modifications needed prior to a large trial.

1 March 2023 in Journal of Urology
Verified
Journal Article
Open access
CHCelestia Higano
Celestia Higano
JHJason Hafron
Jason Hafron
Purpose:In this review, we address adherence rates in clinical settings, barriers to compliance with dosing schedules, and potential strategies to overcome challenges in maintaining high levels of ...